🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1b/2a, open-label, multi-center, dose-escalation and safety...
Status
Completed
Location
Site 2644 University of California, Irvine
Start Date
2018-06-19
Trial ID
NCT03294083
Treatments Being Tested
This is a neoadjuvant Phase 2a, open-label trial in patients with metastati...
Status
Terminated
Location
Ottawa Hospital and Research Institute (OHRI)
Start Date
2011-10
Trial ID
NCT01329809
Treatments Being Tested
This is a Phase I, open-label, dose-escalation trial in patients with advan...
Status
Completed
Location
Billings Clinic
Start Date
2008-06
Trial ID
NCT00625456
Treatments Being Tested
This study is to determine how effectively JX-594 (Pexa-Vec) will prolong l...
Status
Completed
Location
Mayo Clinic
Start Date
2012-06
Trial ID
NCT01636284
Treatments Being Tested
This study is to determine whether JX-594 (Pexa-Vec) plus best supportive c...
Status
Completed
Location
Moores University of California San Diego Cancer Center
Start Date
2011-10-08
Trial ID
NCT01387555
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and effi...
Status
Completed
Location
Mayo Clinic
Start Date
2012-01
Trial ID
NCT01394939
Treatments Being Tested
This is a study to Evaluate the Safety and Efficacy of the Combination of t...
Status
Terminated
Location
Site No 0102
Start Date
2017-07-27
Trial ID
NCT03071094
Treatments Being Tested
The study will be divided into two stages: phase Ib and phase II. The safet...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2021-08-26
Trial ID
NCT04849260
Treatments Being Tested
The purpose of this pilot safety study is to evaluate the safety and tolera...
Status
Completed
Location
Pusan National University Hospital
Start Date
2009-05-26
Trial ID
NCT01171651
Assessment of the efficacy and safety of JX-594 and metronomic cyclophospha...
Status
Unknown
Location
Institut Bergonie
Start Date
2015-09-18
Trial ID
NCT02630368